Xenogen Corporation has announced the launch of its IVIS® 3D Imaging System, the commercial three-dimensional biophotonic imaging system, on display at the Fourth Annual Meeting of the Society for ...

September 15, 2006 (Vol. 26, No. 16) Relying on a More Integrated Approach to Studying Fundamental Biological Processes In the continuing quest to optimize drug discovery, cells and their ...

SAN FRANCISCO (CBS.MW) -- Xenogen Corp. said Tuesday it has signed a five-year global marketing agreement, extending its business partnernship with Merck & Co. . Xenogen said Merck will be using ...

Researchers at Xenogen Corp. have imaged the spontaneous development of tumors in the bladder and pancreas of mice, the company announced Monday. The Alameda company (NASDAQ: XGEN) will formally ...

Xenogen Corp. today agreed to let Biogen Inc. evaluate its real-time in vivo imaging technology in their drug discovery research programs. The Business Journals Select a City ...

HOPKINTON, Mass., Feb. 13 (UPI) -- Caliper Life Sciences Inc. of Massachusetts is offering $80 million in stock for Xenogen Corp., which makes medical imaging technologies.

The drug discovery services company Caliper Life Sciences has struck a deal to acquire Xenogen, which makes imaging systems, for about $80 million. Caliper plans to sell stock and warrants to ...

The first made use of a Xenogen IVIS Lumina imaging system (Caliper Life Sciences) with a thermoelectrically cooled CCD camera. Solid-phase and solution samples were placed on a heated stage set ...

Xenogen Corp., Alameda, Calif., announced that it has closed a $25 million round of financing. Existing investors SR One Ltd., Lombard Odier & Cie, Chevron Technology Ventures and Harvard Private ...

Xenogen rang up a 2003 net loss of $21 million and revenue of $20 million, vs. a loss of $63 million and revenue of $16 million in 2002. The company filed an $86 million IPO in 2000, but withdrew ...